HIV prone occupational exposures: Epidemiology and factors associated with initiation of post-exposure prophylaxis

Journal of Epidemiology and Community Health

Volumn 63, Issue 5, 2009, Pages 373-378

  Zenner, D ^a,b   Tomkins, S ^a   Charlett, A ^a   Wellings, K ^b   Ncube, F ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

BLOOD; DATABASE; DISEASE TRANSMISSION; EPIDEMIOLOGY; GUIDELINE; HEALTH WORKER; HUMAN IMMUNODEFICIENCY VIRUS; OCCUPATIONAL EXPOSURE; PUBLIC HEALTH; REGRESSION ANALYSIS; RISK FACTOR; RISK PERCEPTION;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CORRELATION ANALYSIS; DISEASE TRANSMISSION; FEMALE; HEALTH BEHAVIOR; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NEEDLESTICK INJURY; OCCUPATIONAL EXPOSURE; POST EXPOSURE PROPHYLAXIS; PRACTICE GUIDELINE; RISK FACTOR; UNITED KINGDOM;

ADULT; ANTI-HIV AGENTS; BLOOD-BORNE PATHOGENS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; LOGISTIC MODELS; MALE; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PATIENT ACCEPTANCE OF HEALTH CARE; POPULATION SURVEILLANCE; YOUNG ADULT;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

EID: 66149132725     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2008.081463     Document Type: Article

References (44)

1. Makary MA, Al Attar A, Holzmueller CG, et al. Needlestick injuries among surgeons in training. N Engl J Med 2007;356:2693-2699 (Pubitemid 47001037)
2. Sohn JW, Kim BG, Kim SH, et al. Mental health of healthcare workers who experience needlestick and sharps injuries. J Occup Health 2006;48:474-479 (Pubitemid 46057879)
3. Memish ZA, Almuneef M, Dillon J. Epidemiology of needlestick and sharps injuries in a tertiary care center in Saudi Arabia. Am J Infect Control 2002;30:234-241 (Pubitemid 34596926)
4. Department of Health. HIV Post Exposure Prophylaxis. Guidance from the UK Chief Medical Officers' Expert Advisory Group on AIDS. 2004.
5. Health Protection Agency Centre for Infections. Eye of the Needle. Surveillance of Significant Occupational Exposure to Bloodborne Viruses in Healthcare Workers. http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/1205394781623. 2006
6. Department of Health. HIV Infected Health Care Workers: Guidance on Management and Patient Notification. http://www.dh.gov.uk/prod-consum-dh/groups/ dh-digitalassets/@dh/@en/documents/digitalasset/dh-4116416.pdf. 2005
7. O'Malley EM, Scott RD, Gayle J, et al. Costs of management of occupational exposures to blood and body fluids. Infect Control Hosp Epidemiol 2007;28:774-782 (Pubitemid 47055915)
8. Danila RN, MacDonald KL, Rhame FS, et al. A look-back investigation of patients of an HIV-infected physician. Public health implications. N Engl J Med 1991;325:1406-1411
9. Health Protection Agency Centre for Infections. New HIV Diagnoses Surveillance Tables. UK data to the end of December 2007. http://www.hpa.org.uk/ web/HPAwebFile/HPAweb-C/1207821639612. 2007
10. Young T, Arens F, Kennedy G, et al. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure. Cochrane Database Syst Rev 2007;(1):CD002835.
11. Otten RA, Smith DK, Adams DR, et al. Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). J Virol 2000;74:9771-9775
12. Mori K, Yasutomi Y, Sawada S, et al. Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection. J Virol 2000;74:5747-5753 (Pubitemid 30412940)
13. Tsai CC, Emau P, Follis KE, et al. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol 1998;72:4265-4273 (Pubitemid 28188732)
14. Tsai CC, Emau P, Sun JC, et al. Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection. J Med Primatol 2000;29:248-258
15. Tsai CC, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 1995;270:1197-1199
16. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997;337:1485-1490
17. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-1180
18. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 1999;353:781-785
19. Puro V, Cicalini S, De Carli G, et al. Towards a standard HIV post exposure prophylaxis for healthcare workers in Europe. Euro Surveill 2004;9:40-43
20. Donaldson L. Update to HIV post-exposure prophylaxis (PEP). Guidance from the Expert Advisory Group on AIDS (EAGA) following the recent recall of Viracept (Gateway Reference 8562). http://www.info.doh.gov.uk/doh/embroadcast. nsf/0/1D1582812A934F1A80257322002ED694/$File/ PHL%20HIV%20letter%2024%2007%2007.rtf?OpenElement. 2007
21. Patterson JM, Novak CB, Mackinnon SE, et al. Surgeons' concern and practices of protection against bloodborne pathogens. Ann Surg 1998;228:266-272 (Pubitemid 30191723)
22. Elmiyeh B, Whitaker IS, James MJ, et al. Needle-stick injuries in the National Health Service: a culture of silence. J R Soc Med 2004;97:326-327 (Pubitemid 38918210)
23. Mangione CM, Gerberding JL, Cummings SR. Occupational exposure to HIV: frequency and rates of underreporting of percutaneous and mucocutaneous exposures by medical housestaff. Am J Med 1991;90:85-90.
24. Halpern SD, Asch DA, Shaked A, et al. Inadequate hepatitis B vaccination and post-exposure evaluation among transplant surgeons: prevalence, correlates, and implications. Ann Surg 2006;244:305-309 (Pubitemid 44305547)
25. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: 1987.
26. Royston P. Multiple imputation of missing values. The STATA Journal 2004;4:227-241
27. Rubin D. Inference and missing data. Biometrika 1976;63:581-592
28. Guidelines working group, German R (chair). Updated Guidelines for Evaluating Public Health Surveillance Systems. MMWR 2001;50(RR13):1-35.
29. Heptonstall J, Gill ON, Porter K, et al. Health care workers and HIV: surveillance of occupationally acquired infection in the United Kingdom. Commun Dis Rep CDR Rev 1993;3:R147-53.
30. Burke S, Madan I. Contamination incidents among doctors and midwives: reasons for non-reporting and knowledge of risks. Occup Med (Lond) 1997;47:357-360 (Pubitemid 27416863)
31. Haiduven DJ, Simpkins SM, Phillips ES, et al. A survey of percutaneous/mucocutaneous injury reporting in a public teaching hospital. J Hosp Infect 1999;41:151-154 (Pubitemid 29084010)
32. Benítez R, Ruiz M, Córdoba D, et al. Underreporting of percutaneous exposure accidents in a teaching hospital in Spain. Clinical Performance Quality Health Care 1999;7:88-91.
33. Rapparini C, Saraceni V, Lauria LM, et al. Occupational exposures to bloodborne pathogens among healthcare workers in Rio de Janeiro, Brazil. J Hosp Infect 2006;65:131-137
34. Limb S, Kawsar M, Forster GE. HIV post-exposure prophylaxis after sexual assault: the experience of a sexual assault service in London. Int J STD AIDS 2002;13:602-605
35. Merchant RC, Chee KJ, Liu T, et al. Incidence of visits for health care worker blood or body fluid exposures and HIV postexposure prophylaxis provision at Rhode Island emergency departments. J Acquir Immune Defic Syndr 2008;47:358-368
36. Puro V, Cicalini S, De Carli G, et al. Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European setting. Eur J Epidemiol 2004;19:577-584 (Pubitemid 39005420)
37. Sidwell RU, Green JS, Novelli V. Management of occupational exposure to HIV - what actually happens. Commun Dis Public Health 1999;2:287-290
38. Patel D, Gawthrop M, Snashall D, et al. Out of hours management of occupational exposures to blood and body fluids in healthcare staff. Occupational Environ Med 2002;59:415-418 (Pubitemid 34634222)
39. Merchant RC, Keshavarz R. HIV postexposure prophylaxis practices by US ED practitioners. Am J Emerg Med 2003;21:309-312 (Pubitemid 36959133)
40. Becker MH. The Health Belief Model and Personal Health Behavior. Health Education Monographs 1974;2:324-473.
41. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. New Jersey: Prentice-Hall, 1980.
42. De Carli G, Puro V, Binkin NJ, et al. Risk of human immunodeficiency virus infection for emergency department workers. Italian Study Group on Occupational Risk of HIV Infection. J Emerg Med 1994;12:737-744
43. Wood AJ, Nadershahi NA, Fredekind RE, et al. Student occupational exposure incidence: perception versus reality. J Dent Educ 2006;70:1081-1088
44. Cutter J, Jordan S. Uptake of guidelines to avoid and report exposure to blood and body fluids. J Adv Nurs 2004;46:441-452 (Pubitemid 38687015)